Terrill K. McClanahan - Researcher Profile

Publications

2 shown

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Tanguy Y. Seiwert , Barbara Burtness , Ranee Mehra +9 more

2016 The Lancet Oncology 1684 citations

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Claire L. Langrish , Yi Chen , Wendy M. Blumenschein +6 more

Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper ...

2005 The Journal of Experimental Medicine 3991 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,675
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.